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Shanna L Gustafson, M.S. 
University of Pittsburgh, 2006 
 
Sickle cell trait carriers are healthy; however, they are at risk to have children with sickle cell 
disease (SCD), a serious hematologic disorder. Unsuccessful population screening for sickle cell 
trait (SCT) has resulted in a large population of African American individuals entering 
childbearing age with no knowledge of their risk. Recent experience with newborn screening 
follow-up of hemoglobinopathies has shown that interest in genetic screening for SCT is low. 
This study aims to understand and increase the level of acceptance of genetic screening among 
the African American population through a program of education and assessment of the current 
state of SCD cultural health beliefs. This is important for Public Health because SCD is the most 
common genetic disorder affecting the African American community and education to promote 
screening must be sensitive to the cultural beliefs of the community.  
 Utilizing a method of anonymous surveys given to female African American 
patients within a busy prenatal clinic the effect of education of SCD on the acceptance of genetic 
screening for SCT has been assessed. The Health Belief Model was used to assess the current 
state of health beliefs regarding SCD and trait testing through anonymous surveys.  
This study revealed that a brief educational intervention regarding SCD in a prenatal 
setting is effective in significantly increasing knowledge of SCD and acceptance of screening for 
SCT (p-value < 0.001). African American women of childbearing age have a high perception of 
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severity of SCD, a low perception of susceptibility to SCD, a high perception of benefit to SCT 
testing and a low perception of barriers to testing for SCT. 
Education within a prenatal setting can be used as a model to increase acceptance of 
screening for SCT. A high level of knowledge of SCD is associated with a high level of 
acceptance; however, the Health Belief Model revealed that currently the majority of the 
participants do not feel that they are personally at risk to have a child with SCD, regardless of 
SCD knowledge. Future education of SCD must take into account these beliefs in order to 
effectively motivate interest in SCT testing.  
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1.0  INTRODUCTION 
The Children’s Hospital of Pittsburgh Comprehensive Sickle Cell Program is contracted by the 
Commonwealth of Pennsylvania for the notification and follow-up of abnormal 
hemoglobinopathy newborn screening results for the 32 county area of Western Pennsylvania. 
Approximately 245,000 African Americans live within this area. Each year over 600 newborns 
are found to carry a hemoglobinopathy trait and 12-15 are diagnosed with sickle cell disease 
(SCD). 100% of newborns identified to have SCD have been brought into the comprehensive 
care center and started on prophylactic penicillin since 1997 (Kladny, Gettig, & Krishnamurti, 
2005). However, less than 10% of families notified of a hemoglobinopathy trait identified in 
their infant have accepted an offer of formal genetic counseling and extended family testing 
(Kladny, Gettig, & Krishnamurti, 2005).  
In genetic screening programs, participation of the target population is the key to success. 
Historically, population screening programs for the detection of SCD and sickle cell trait (SCT) 
have been controversial. The National Sickle Cell Anemia Control Act, enacted in 1972 quickly 
developed public screening programs; however, much of the benefit that may have been 
accomplished was overshadowed by the limits of hasty planning which did not involve members 
of the target African American population, poor control, lack of education and improper testing 
procedure (Scott & Castro, 1979). Mandatory population testing of the African American 
population and inability to distinguish trait from disease led to the improper labeling of people, 
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as well as unnecessary fear and discrimination (Scott & Castro, 1979). Eventually the program 
was abandoned and other screening programs had to be developed. 
Newborn screening for hemoglobinopathies has been a more successful form of 
population screening for SCD and SCT, with the majority of states establishing programs of 
screening for hemoglobinopathies by the mid 1980’s. However, the primary goal of newborn 
screening for hemoglobinopathies has been to identify infants with SCD who would benefit from 
immediate care, leaving many of the infants identified as trait carriers to go uninformed. Many of 
these trait infants are now entering the childbearing ages with no knowledge of their trait status. 
This is an adult population that would benefit from screening for SCT and genetic counseling 
concerning the possible risks for their children to be affected with SCD; unfortunately, 
experience has shown that interest in testing and genetic counseling is low among the at risk 
African American population. 
Knowledge of the disorder as well as cultural views, health beliefs, social and economic 
barriers may be contributors to the lack of interest and support for SCT testing and genetic 
counseling among the African American community. This study aims to increase and understand 
the level of acceptance of genetic testing and genetic screening among the African American 
population through a program of education and assessment of the current state of SCD cultural 
health beliefs among the target population. 
 2 
2.0  SPECIFIC AIMS 
2.1 SPECIFIC AIM I 
Knowledge of Sickle Cell Disease and Acceptance of Genetic Testing and Counseling: 
Specific Aim: To improve the acceptance of genetic testing and genetic counseling for sickle 
cell trait (SCT) among the African American female community of childbearing age by 
increasing the knowledge of sickle cell disease (SCD) through individual education sessions.  
 
Hypothesis: The lack of interest in genetic testing for SCT among the African American 
community may be due to a lack of knowledge of SCD and the risks associated with SCT. 
Acceptance can be improved by increasing the communities’ knowledge of SCT.   
 
Plan: Utilizing anonymous paired surveys, assessment of knowledge of SCD and acceptance of 
genetic testing and genetic counseling for SCT was performed prior to and following the 
administration of a brief individual educational session. The effectiveness of the educational 
session will be analyzed as well as the relationship of knowledge of SCD with acceptance of 
genetic testing.  
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2.2 SPECIFIC AIM II 
Knowledge of Sickle Cell Disease and the Health Belief Model: 
Specific Aim: To determine the current health beliefs of the African American female 
community of childbearing age regarding SCD and genetic testing for SCT.  
 
Hypothesis: Participants in a voluntary genetic screening program will have a high level of 
perceived severity of SCD, a high level of perceived susceptibility, a high level of perceived 
benefit to testing, and a low level of perceived barriers to testing. Identifying the current status of 
health beliefs will determine areas of education that must be stressed in order to increase interest 
in genetic testing for SCT.  
 
Plan: Utilizing anonymous surveys among the African American community of childbearing 
age, the current state of SCD and SCT testing health beliefs will be analyzed. Assessment of 
knowledge of SCD will also be studied to determine a correlation with health beliefs.  
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3.0  BACKGROUND AND SIGNIFICANCE 
3.1 SICKLE CELL DISEASE 
Sickle cell disease (SCD), also known as sickle cell anemia, is an autosomal recessive genetic 
hematologic disorder that results from mutations in both copies of the β-globin gene, a major 
subunit of hemoglobin. Individuals with only one mutated β-globin gene and one normal 
working copy are known as sickle cell trait (SCT) carriers. Sickle cell trait carriers are healthy 
and will not develop SCD. The characteristic phenotype of SCD includes an altered 
polymerization of hemoglobin resulting in a “sickled” shape to the red blood cells (Figure 1). 
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Figure 1: Sickled Red Blood Cells (www.samc.com, 4/2/2006) 
 
 
Polymerization can result in varied characteristics of hemolysis and vascular occlusion 
which can lead to tissue ischemia and organ complications. SCD can occur through 
homozygosity for the sickle (S) β-globin mutations which results in the more severe form of 
SCD.  SCD is also caused by compound heterozygosity of S β-globin mutations with other 
variant β globin gene mutations (Wilson, Krishnamurti, & Kamat, 2003). Examples of this 
include, but are not limited to, SC Disease, Sickle-β thalassemia, SE disease and SOarab (Wilson, 
Krishnamurti, & Kamat, 2003). Variations of SCD can exhibit a range of phenotypes from mild 
to severe, however the expression of severity is unpredictable based on genotype. Homozygosity 
of other variant β-globin mutations can also result in other serious hematologic disorders such as 
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hydrops fatalis or Cooley’s anemia. Within this manuscript, the term sickle cell disease (SCD) 
will encompass all of the variant forms of SCD and the typical presentation.   
3.1.1 Incidence of Sickle Cell Disease 
Sickle cell disease is the most common single gene disorder among the African American 
population, with an estimated one in every 375 individuals of African American descent 
affected. Approximately 1 in every 12 African Americans carry a SCD β-globin mutation (Doris 
L Wethers, 2000; Lonergan, Cline, & Abbondanzo, 2001). In the United States, approximately 
2,000 infants are born each year affected with SCD (Wilson, Krishnamurti, & Kamat, 2003). Hb 
S is the most common β globin mutation found within individuals of African descent, followed 
by the Hemoglobin C β globin mutation (Doris L Wethers, 2000). People of Mediterranean, 
Middle Eastern, Indian, Caribbean and Central and South American descent are also at an 
increased risk to carry a mutation in their β-globin chains and be affected with a form of SCD or 
similar hemoglobinopathy (Doris L Wethers, 2000; Karnon et al., 2000; Lonergan, Cline, & 
Abbondanzo, 2001; Wilson, Krishnamurti, & Kamat, 2003). Figure 2 displays areas of origin in 
red, which have a high incidence of hemoglobinopathy carriers.  
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Figure 2: Areas of Increased Hemoglobinopathy Incidence 
 
 
Individuals who are heterozygous for HbA (adult hemoglobin) and a β-globin variant are carriers 
for SCD, also known as sickle cell trait (SCT). Carriers for SCD do not typically manifest 
symptoms of the disorder as they have at least 50% normal hemoglobin; however, they may 
appear anemic due to the reduced expression of normal β globin subunits (Doris L Wethers, 
2000). Awareness of carrier status is important because SCT carriers can pass on their variant 
gene to their children. Couples where both individuals are carriers of a β-globin variant have a 
25% chance with each pregnancy that their child will have SCD, a 50% chance that their child 
will also be a carrier, and a 25% chance that their child will not be affected or a carrier (Karnon 
et al., 2000).  
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3.1.2 Natural History of Sickle Cell Disease 
Sickle cell disease was first described in 1910 (Herrik, 1910). Since that time, understanding of 
the pathophysiology of SCD has increased resulting in effective treatment and reducing 
morbidity and mortality. Characteristic complications of SCD are the result of the hemoglobin 
polymerization and sickling shape of the red blood cells. Sickled red blood cells are rigid, sticky 
and elongated, increasing vasoocclusion as well as a causing a hemolytic state due to the 
decreased lifespan of these cells. There are many characteristic phenotypes that result due to the 
polymerization of the sickle hemoglobin. Acute complications include severe pain crisis; strokes; 
acute chest syndrome; splenic sequestration; and an increased risk of sepsis or other infections as 
well as many others (Karnon et al., 2000).  
The acute-vasoocclusive event or pain crisis is the hallmark feature of SCD, which  limits 
oxygen supply and causes tissue ischemia (Claster & Vichinsky, 2003; Wethers, 2000b; Wilson, 
Krishnamurti, & Kamat, 2003). Pain crisis are common and unpredictable. Pain crisis is a 
difficult complication of SCD and clinicians must trust patient self report in order to determine 
the best standard of treatment (Claster & Vichinsky, 2003; Wethers, 2000a, , 2000b; Wilson, 
Krishnamurti, & Kamat, 2003). The earliest symptom of vasoocclusion is the “hand-foot 
syndrome” or dactylitis (Figure 2) which is a swelling of the hands and feet of an infant with 
sickle cell disease caused by pooling and occlusion of the blood vessels. 
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Figure 3: Dactylitis or “Hand-Foot Syndrome”. 
(http://web.uct.ac.za/depts/ich/teaching/temp/tb_scenarios/case%205/tbs_c05.html, 4/2/2006) 
 
 
Acute chest syndrome (ACS) is a serious complication of SCD involving the 
development of infiltrates in the pulmonary system and can include infections (Claster & 
Vichinsky, 2003; Karnon et al., 2000; Wethers, 2000b; Wilson, Krishnamurti, & Kamat, 2003).  
ACS can also include symptoms of fever, chest pain, wheezing and cough and may present 
following or with other acute symptoms. Early treatment of ACS is important because 
advancement can progress to respiratory failure and death (Claster & Vichinsky, 2003; Wethers, 
2000a, , 2000b; Wilson, Krishnamurti, & Kamat, 2003).  
Splenic sequestration is characterized by a rapidly enlarged spleen which can lead to a 
decrease in hemoglobin production and an increased risk for infection (Claster & Vichinsky, 
2003; Wethers, 2000a, , 2000b; Wilson, Krishnamurti, & Kamat, 2003). Without treatment, cases 
can lead to death.  
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Approximately 10% of all SCD patients will have a stroke at some time in their lives, 
with the peak incidence occurring between the ages of 4 and 6 (Claster & Vichinsky, 2003; 
Wethers, 2000a, , 2000b; Wilson, Krishnamurti, & Kamat, 2003). Strokes occur secondary to 
vasoocclusion within the blood vessels of the brain, limiting oxygen levels and causing 
hemiparesis, headache, cranial nerve palsy, and dysphagia (Claster & Vichinsky, 2003; Wethers, 
2000a, , 2000b; Wilson, Krishnamurti, & Kamat, 2003). Some strokes can be small and go 
unnoticed, leading to reduced ability to learn and function with no identifiable cause.  
Another common complication affecting males with SCD is priapism, or prolonged 
painful erections due to vasoocclusion (Claster & Vichinsky, 2003; Wethers, 2000a, , 2000b; 
Wilson, Krishnamurti, & Kamat, 2003). Almost 90% of males with SCD will experience 
priapism by age 20. Prolonged priapism may result in organ damage and impotence if untreated.  
Renal complications can also be manifestations of SCD. Due to the fragility of the 
kidneys, these organs are prone to damage by the inflexible sickled red blood cells (Claster & 
Vichinsky, 2003; Wethers, 2000a, , 2000b; Wilson, Krishnamurti, & Kamat, 2003). Children 
with SCD are also prone to gallstones. Monitoring of these organs is warranted to prevent 
damage and consider surgery or other treatments (Claster & Vichinsky, 2003; Wethers, 2000a, , 
2000b; Wilson, Krishnamurti, & Kamat, 2003).  
Although serious health concerns for a child with SCD are numerous, there are also many 
psychological effects that must be addressed in treatment as well. Adolescence is a particularly 
difficult time for patients with SCD. Children with SCD often are slow in growth and 
development (Wethers, 2000a). The social effects of missed school, limitations in activity, and 
repeated hospitalizations can also cause distress to an adolescent with SCD. These issues along 
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with reproductive genetic counseling should all be addressed with the patient that is growing up 
with SCD (Wethers, 2000a). 
3.1.3 Treatment of Sickle Cell Disease 
Painful vasoocclusive crisis is often the result of bone marrow infarction and can vary in 
intensity with extreme pain crisis treated with opiates such as morphine and extended 
hospitalizations, with emphasis on hydration and management of any infections that may 
precipitate further crisis. Studies have also shown a significant reduction in occurrence of painful 
crisis in correlation with a high percentage of fetal hemoglobin or Hb F. Treatment with 
hydroxyurea induces expression of Hb F and a reduction in incidence of crisis (Ballas, 2002; 
Platt et al., 1994).  
 Treatment for acute chest syndrome includes pain management as well as oxygenation, 
hydration, antibiotics and blood transfusions. Splenic sequestration occurs most often in children, 
with splenic enlargement occurring suddenly requiring transfusion and immediate treatment. In 
some cases this can be recurrent and surgical splenic removal should be considered due to the 
risk of fatal complications (Karnon et al., 2000). Patients with SCD are at an increased risk for 
all types of blood sepsis. Prophylactic penicillin has been shown to significantly reduce the 
incidence of pneumococcal sepsis among infants with SCD, increasing the importance for early 
identification and treatment of SCD (Gaston, Verter, Woods, & et, 1986; Karnon et al., 2000). 
Standard childhood immunizations are recommended for all children, particularly children with 
SCD due to the high susceptibility to infection. Immunizations include the pneumococcal 
vaccines; yearly influenza vaccination; as well as meningococcal vaccination for children with 
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splenic dysfunction (Claster & Vichinsky, 2003; Wethers, 2000b; Wilson, Krishnamurti, & 
Kamat, 2003). 
Approximately 10% of patients with Hb SS will experience a stroke due to vasoocclusion 
(Karnon et al., 2000). Patients identified at an increased risk for an initial or second stroke are 
monitored with Transcranial Doppler (TCD) imaging and receive regular blood transfusions in 
order to reduce the percentage of sickled cells within the blood stream, this type of follow up has 
shown to decrease the risk for stroke by ten-fold (16% risk to 1.6%) (Adams, McKie, Hsu, Files,  
1998; Karnon et al., 2000).   
SCD is rarely curable; however, in some cases bone marrow or stem cell transplant has 
been shown to be successful with minimal recurrence and mortality (Walters et al., 2000). 
Unfortunately, difficulties may arise in locating sufficient HLA matched donors, limiting the 
number of candidate patients for this procedure.  
3.1.4 Molecular Genetics of Sickle Cell Disease 
The healthy adult hemoglobin (HbA) molecule is made of two α globin chains and two β globin 
chains that bind oxygen in erythrocytes for transport throughout the body. Mutations within the 
genes which code for the α or β globin protein subunits can result in an imbalance of globins that 
disrupt the function and oxygen binding ability of red blood cells (Nussbaum, McInnes, & 
Willard, 2004). Abnormal hemoglobins are designated by the type of mutations present within 
these globin chains. For example, homozygous sickle cell disease is designated as HbSS, 
compound heterozygotes formed by one S β-globin chain and one C β-globin chain is 
distinguished Hemoglobin SC disease (Lonergan, Cline, & Abbondanzo, 2001; Nussbaum, 
McInnes, & Willard, 2004; Steinberg & Brugnara, 2003). Homozygous HbSS and S β-
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thalassemia are considered the most severe forms of SCD (Lonergan, Cline, & Abbondanzo, 
2001; Wilson, Krishnamurti, & Kamat, 2003). 
Characteristics of SCD are a result of the unique properties of the hemoglobin molecules, 
leading to vasoocclusion and hemolytic anemia. In Hb S a single point mutation results in a 
glutamic acid replacing valine (Figure 3).  
 
 
 
 
 
Figure 4: Hemoglobin S Mutation (http://evolution.berkely.edu, 4/2/2006) 
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This results in binding of Hb S chains and polymerization when deoxygenated, leading to 
rigid polymerized hemoglobin molecule (Figure 4).  
 
 
 
Figure 5: Binding and Polymerization of Hemoglobin S Molecules (Steinberg 1999) 
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These molecules distort the shape of the red blood cells into a stiff elongated “sickle” 
shape (Ballas, 2002; Lonergan, Cline, & Abbondanzo, 2001; Nussbaum, McInnes, & Willard, 
2004; Steinberg & Brugnara, 2003; Wilson, Krishnamurti, & Kamat, 2003). Polymerization 
occurrence depends on multiple factors including deoxygenation, increased hemoglobin 
concentration, dehydration, acidity, temperature, and the presence of other hemoglobins, such as 
fetal hemoglobin which inhibits polymerization. Polymer formation is reversible with 
oxygenation; however, polymerization causes an increase in the membrane permeability for 
sodium, potassium, magnesium and calcium, leading to further dehydration of the red blood 
cells. Increased hemoglobin density accelerates polymerization further adding to the cycle of red 
blood cell sickling (Ballas, 2002; Lonergan, Cline, & Abbondanzo, 2001; Nussbaum, McInnes, 
& Willard, 2004; Steinberg & Brugnara, 2003). These polymerization/depolymerization cycles 
contribute to the increased hemolysis of SCD decreasing the lifespan of erythrocytes to as few as 
20 days, as compared to the 120 day lifespan of healthy red blood cells. The deformed sickled 
shape of the red blood cells also decreases the red blood cells ability to pass through the blood 
vessels leading to vascular occlusion. It is also believed that the red blood cells in SCD have an 
affinity to bind to the vascular endothelium due to surface complexes that bind thrombospondin 
or other plasma proteins which promote adhesion to vascular endothelium, and reduce the ability 
for blood vessel relaxation (Ballas, 2002; Lonergan, Cline, & Abbondanzo, 2001; Nussbaum, 
McInnes, & Willard, 2004; Steinberg & Brugnara, 2003). 
Other mutations within the β globin genes, when forming compound heterozygotes with 
Hb S, can result in features similar to Homozygous Hb SS sickle cell disease. Normal adult 
hemoglobin is maintained with an equal balance of α globin and β globin chains. Mutations that 
disrupt this careful balance can lead to a range of hematologic disorders (Doris L Wethers, 2000; 
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Nussbaum, McInnes, & Willard, 2004). For example, the βº thalassemia mutation results in a 
lack of expression of that β globin chain. If this mutation is inherited with the Hb S mutation, 
only Hb S will be expressed resulting in the SCD phenotype. Other hemoglobin variants that can 
cause complications when inherited with an Hb S mutation are the Hb C mutation, Hb O-Arab, 
Dpunjab, Hb E and β+ thalassemia (Doris L Wethers, 2000; Karnon et al., 2000; Wilson, 
Krishnamurti, & Kamat, 2003).  
3.2 NEWBORN SCREENING FOR SICKLE CELL DISEASE 
Newborn screening is used to describe the panel of tests performed on a newborn within the first 
few hours of life that are traditionally used to detect inherited metabolic disorders. The beginning 
of newborn screening is marked by the discovery of a blood screening test by Guthrie in the 
1960’s that could be used to detect phenylketonuria, a metabolic disorder when untreated results 
in mental retardation. In asymptomatic newborns this test provides the ability to perform dietary 
intervention and prevent catastrophic health outcomes (Guthrie & Susi, 1963). Since that time 
numerous screening tests have been developed for newborns, with large differences in testing 
panels between states. Development of new testing panels have been influenced by government 
policy, scientific discovery, financial incentives, and political pressures (Therrell, 2001). Infants 
born in one state may not be screened for the same panel of disorders as an infant born in a 
neighboring state. Criteria for including a new disorder within a newborn screening panel are 
shown in Table 1 (Kenneth A Pass, 2000; K. A. Pass et al., 2000).  
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Table 1: Recommended Criteria for Including a New Disorder within a Newborn Screening Panel 
 
RECOMMENDED CRITERIA FOR INCLUDING A NEW DISORDER WITHIN A NEWBORN 
SCREENING PANEL (KENNETH A PASS, 2000; K. A. PASS ET AL., 2000) 
1)  Test should be accurate, specific and sensitive for the disorder and can be integrated in to the current 
testing protocol 
2)  Testing of widespread populations is cost effective 
3)  Disorder of interest should have a high enough incidence within the general population to warrant 
testing 
4)  Testing should provide measurable benefit to the newborn such as a substantial benefit to early 
treatment 
 
 
Newborn screening for hemoglobinopathies began as a research protocol in the 1960’s; 
however, clinical programs with established follow up were not established until 1975 in New 
York (Olney, 2000). Until studies were established linking reduction of infant mortality due to 
sepsis following treatment of prophylactic penicillin, establishment of statewide programs for 
hemoglobinopathies  was slow (Olney, 2000). In 1987, Gaston and colleagues significantly 
demonstrated an improved prognosis for children with SCD on prophylactic penicillin.  In a 
randomized multi-center trial of prophylactic oral penicillin given to children with SCD, the 
incidence of infection was reduced by 85% when compared to the placebo group (Gaston, 
Verter, Woods, & et, 1986). This discovery provided incentive and evidence of the benefits of 
early diagnosis of sickle cell disease. Following this discovery the National Institute of Health 
(NIH) consensus development conference recommended the initiation of universal mandatory 
newborn screening for sickle cell disease (Anonymous, 1987a, , 1987b). As of January, 2006, 49 
states and the District of Columbia require universal newborn screening for SCD. According to 
the National Newborn Screening and Genetics Resource Center, New Hampshire has required 
screening, but has not yet implemented universal newborn screening for sickle cell disease 
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(http://genes-r-us.uthscsa.edu/, 4/2/2006). Some controversy existed in early development of 
hemoglobinopathy newborn screening programs in the establishment of whether screening 
should be targeted or universal. Targeted screening would perform testing only within 
populations deemed to be at high risk, while universal screening would test all infants born. State 
legislation has determined each individual states’ protocol; however, deficiencies have been 
noted in targeted screening such as lack of cost effectiveness, logistics of targeting infants, and 
ability to miss affected infants due to mixed ancestry (Olney, 2000).  
The primary purpose of screening newborns for SCD is the diagnosis of homozygous 
sickle cell disease for the purpose of beginning oral prophylactic penicillin, and implementing a 
relationship with a comprehensive sickle cell care team.  Comprehensive sickle cell care 
programs are primarily located in large medical centers, with only 11 comprehensive centers 
endorsed by the National Institutes of Health (NIH, 2/2/2006). Experience since the 
implementation of newborn screening programs suggests that rates of morbidity and mortality 
due to sickle cell disease can be significantly reduced by such programs if they are linked to 
comprehensive clinical management systems that include parental education. (Davis, 2000; Lee, 
Phoenix, Jackson, & Brown, 1999; Leikin et al., 1989; Powars, Hiti, Ramicone, Johnson, & 
Chan, 2002; Quinn, Rogers, & Buchanan, 2004). Although a large portion of children and 
families affected by sickle cell disease are covered by these established centers, there are many 
families that do not live within a reasonable distance of a care team and who trust and prefer to 
be cared for by their regular pediatrician. 
Newborn screening for hemoglobinopathies such as SCD also detects heterozygous 
carriers of SCT. While follow-up of the child identified as heterozygous for a hemoglobinopathy 
requires no specialized medical care there are several social and genetic counseling implications 
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of the notification of sickle cell or other hemoglobinopathy trait ("Consensus conference. 
Newborn screening for sickle cell disease and other hemoglobinopathies", 1987).  A newborn 
detected to have SCT, provides an opportunity to offer testing  and genetic counseling to a 
couple that may be at risk to have a child with SCD in a future pregnancy (Grover, 1989; Laird, 
Dezateux, & Anionwu, 1996). Information provided should explain that the carrier state is not a 
disease, that there may be implications for other family members, and that depending on results 
of family studies, future children may be at risk for a significant hematologic disorder (Whitten, 
Thomas, & Nishiura, 1981). The implications of sickle cell trait within a family are important 
information to be shared with the entire family, primarily members that are within or entering the 
childbearing age.  
The ideal age for carrier screening is prior to the initiation of a pregnancy, when mature 
decisions can be made concerning pursuing testing and utilizing the information obtained from 
results (D'Souza et al., 2000). This information has the ability to affect family relationships and 
should be imparted sensitively with care taken of the families needs. Ideally this should be 
performed in a clinical setting with the assistance of a trained genetic counselor; however, in 
many states counseling of families is left to the infant's primary care physician or perhaps is not 
done at all.  
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3.3 SICKLE CELL TRAIT POPULATION SCREENING 
Although screening for sickle cell disease and sickle cell trait is now performed through newborn 
screening as discussed above, this strategy of follow up for infants identified to be trait carriers is 
relatively new, leaving a large population of trait carriers unidentified and entering the 
childbearing age.  
Population screening programs for sickle cell trait have been attempted unsuccessfully in 
the past. The National Sickle Cell Anemia Control Act, enacted in 1972 by the 92nd Congress of 
the United States, enforced mandatory sickle cell screening laws for the African American 
population (Grossman, Holtzman, Charney, & Schwartz, 1985; Olney, 2000). These laws were 
written and passed without caution to avoid stigmatization of individuals found to have SCD as 
well as those identified to be carriers of SCT (Grossman, Holtzman, Charney, & Schwartz, 
1985).  These early screening programs have received criticism for insensitivity to issues of race 
and culture, inadequate education of participants and workers, inaccurate testing procedures, and 
protection of the participants privacy (Grossman, Holtzman, Charney, & Schwartz, 1985).  
Successful recruitment of African Americans for health screening studies has been based 
upon cultural sensitivity and voluntary involvement of the target population (Paskett, 
DeGraffinreid, Tatum, & Margitic, 1996).  Most health prevention and control research studies 
have been limited in their ability to access the African American population, resulting in an 
under representation of this population in health research (Paskett, DeGraffinreid, Tatum, & 
Margitic, 1996). Planning to incorporate the barriers, beliefs and concerns of African Americans 
can improve recruitment and participation (Paskett, DeGraffinreid, Tatum, & Margitic, 1996). 
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Success in recruitment has been reported in many screening programs and research studies for 
African Americans that have utilized strategies which include multiples characteristics. Table 2 
summarizes some of these studies and strategies used for recruitment (K. T. Ashing-Giwa, 
Padilla, Tejero, & Kim, 2004; Chan, Haynes, O'Donnell, Bachino, & Vernon, 2003; Fouad et al., 
2000; Freimuth et al., 2001; B. L. Green et al., 2000; Jones & Broome, 2001; Paskett, 
DeGraffinreid, Tatum, & Margitic, 1996; Weinrich et al., 1998; Woods, Montgomery, & 
Herring, 2004).  
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 Table 2: Strategies for Recruitment of African Americans for Health Research and Screening Behaviors 
 
YEAR 
PUBLISHED 
REFERENCE SUMMARY OF RECRUITMENT STRATEGIES 
1996 Paskett, E., C. DeGraffinreid, et al. 
(1996). "The recruitment of African 
Americans to cancer prevention and 
control studies." Preventative Medicine 
25: 547-553 
1: Adequately characterize target population 
2: Involve members of target population in 
planning efforts 
3: Take the message to the target population 
4: Give something back to the community 
5: Enhance study credibility by using a community    
spokesperson 
6: Identify and remove barriers to participation 
7: Improve staff sensitivity 
8: Educate the target population about the 
importance of prevention and early detection 
 
1996 Voorhees, C. C., F. A. Stillman, et al. 
(1996). "Heart, body, and soul: impact 
of church-based smoking cessation 
interventions on readiness to quit." 
Prev Med 25(3): 277-85. 
 
1: Utilize a respected common meeting ground such 
as a community church 
1998 Weinrich, S., D. Holdford, et al. 
(1998). "Prostate cancer education in 
African American churches." Public 
Health Nursing 15(3): 188-95 
 
1: Utilize a respected common meeting ground such 
as a community church 
 
2000 
Fouad, M. N., E. Partridge, et al. 
(2000). "Minority recruitment in 
clinical trials: a conference at 
Tuskegee, researchers and the 
community." Annals of Epidemiology 
10(8 Suppl): S35-40. 
1: Establish an open dialogue between community 
members and researchers  
2: Establish a respectful partnership with 
community members from the initial stages of 
research 
 
2000 Green, B. L., E. E. Partridge, et al. 
(2000). "African-American attitudes 
regarding cancer clinical trials and 
research studies: results from focus 
group methodology." Ethnicity & 
Disease 10(1): 76-86. 
1: Active communication with members of target  
community 
2001 Freimuth, V. S., S. C. Quinn, et al. 
(2001). "African Americans' views on 
research and the Tuskegee Syphilis 
Study." Soc Sci Med 52(5): 797-808 
1: Enhance knowledge and understanding of 
research 
2: Improve trust and clarify informed consent 
procedures 
3: Stress importance of research 
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Table 2 
(cont’d): 
YEAR 
PUBLISHED 
REFERENCE SUMMARY OF RECRUITMENT STRATEGIES 
2001 Jones, F. C. and M. E. Broome (2001). 
"Focus groups with African American 
adolescents: enhancing recruitment and 
retention in intervention studies." 
Journal of Pediatric Nursing 16(2): 88-
96. 
 
1: Increase knowledge of the disease 
2: Clarify expectations of research including time 
and incentives for participation 
3: Utilize study coordinators that can form a 
trusting relationship with participants 
4: Make research interesting for participants 
 
2003 Chan, E., M. Haynes, et al. (2003). 
"Cultural sensitivity and informed 
decision making about prostate cancer 
screening." Journal of Community 
Health 28: 393-405. 
 
1: Target education and material towards the 
cultural differences of the target community 
2004 Ashing-Giwa, K. T., G. V. Padilla, et 
al. (2004). "Breast cancer survivorship 
in a multiethnic sample: challenges in 
recruitment and measurement." Cancer 
101(3): 450-65. 
 
1: Utilized telephone calls and recruitment 
invitations, as well as accommodating preferences 
of contact of participants. 
2: Matched follow up calls with linguistically 
matched interviewers 
 
2004 Frank, D., J. Swedmark, et al. (2004). 
"Colon cancer screening in African 
American women." ABNF Journal 
15(67-70). 
 
1: Target education towards the health beliefs of the 
target community 
2: Faith based education is also useful 
 
2004 Green, P. M. and B. A. Kelly (2004). 
"Colorectal cancer knowledge, 
perceptions, and behaviors in African 
Americans." Cancer Nursing 27(3): 
206-15; quiz 216-7 
1: Increase awareness of the disorder 
2: Target the health beliefs of the community 
3: Educate on the importance of screening 
2004 Woods, V., S. Montgomery, et al. 
(2004). "Recruiting Black/African 
American men for research on prostate 
cancer prevention." Cancer 100(1017-
1025). 
1: Tailor printed and educational materials to the 
target culture 
2: Utilize targeted locations frequented by the target 
population 
3: Participatory approach  
4: Train staff to be sensitive and culturally aware 
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These strategies include adequate characterization of the target population, involvement 
of members of the target population in the planning process, taking the message to the target 
population, providing a return to the community, partnerships with credible community 
representatives, identification and removal of barriers, staff cultural sensitivity and improving 
education of the target population about the benefits of early diagnosis and treatment (Chan, 
Haynes, O'Donnell, Bachino, & Vernon, 2003; Woods, Montgomery, & Herring, 2004).  
In regards to sensitive screening programs and promotion, special respect towards 
cultural beliefs should be incorporated into educational design and intervention. Cultural 
sensitivity in a respectful, caring, personalized ethnic approach with involvement of the target 
population in the planning and implementation process are the keys to successful recruitment and 
participation (K. T. Ashing-Giwa, Padilla, Tejero, & Kim, 2004; Chan, Haynes, O'Donnell, 
Bachino, & Vernon, 2003; Fouad et al., 2000; Frank, Swedmark, & Grubbs, 2004; Freimuth et 
al., 2001; B. L. Green et al., 2000; P. M. Green & Kelly, 2004; Jones & Broome, 2001; Lewis & 
Green, 2000; Paskett, DeGraffinreid, Tatum, & Margitic, 1996; K. O. Plowden, 1999; Voorhees 
et al., 1996; Weinrich et al., 1998; Woods, Montgomery, & Herring, 2004).  
In 1994, the National Institutes of Health (NIH)-Department of Energy (DOE) Working 
Group on Ethical, Legal and Social Implications (ELSI) of Human Genome Research convened 
the Task Force on Genetic Testing to make recommendations to ensure the development systems 
ensuring safety and effectiveness to genetic testing (N. A. Holtzman, 1999; N. A. Holtzman & 
Watson, 1999). Based on its deliberations  and the historical review of the sickle cell, Tay-Sachs, 
neural tube defects, and Down syndrome screening programs the  Task Force on Genetic Testing  
made the following recommendations regarding the conduct of genetic screening program in 
order for success (Table 3) (N. A. Holtzman, 1999; N. A. Holtzman & Watson, 1999). 
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Table 3: Recommendations on the Conduct of Genetic Screening Programs 
 
RECOMMENDATIONS BY THE TASK FORCE OF GENETIC TESTING FOR THE CONDUCT OF 
GENETIC SCREENING PROGRAMS 
(N. A. HOLTZMAN, 1999; N. A. HOLTZMAN & WATSON, 1999; N. M. D. HOLTZMAN, MPH & 
WATSON, 1997) 
1)  Genetic screening programs must be implemented being aware of the sensitivity of the needs of the 
groups screened and the inclusion of those groups in the planning of screening programs in order to frame 
the diagnosis and understanding of genetic disease with respect to issues of race, ethnicity, and gender.   
 
2)  Patients, physicians, and genetic counselors must understand what these tests actually predict or diagnose 
in order to ensure that patients make fully informed, autonomous decisions about the test results.   
 
3)  Unrelenting vigilance is necessary on the validity of tests and the reliability of the laboratories providing 
them, both as the tests are developed and as they are used on large numbers of people.   
 
4)  It is important to consider how these test results may affect other family members.   
 
5)  Confidentiality of the information discovered is vital.  
 
6)  The impact of a genetic diagnosis on the patient's health or life insurance status must be carefully 
considered. 
 
7)  The ethical dilemma posed by disease avoidance using pregnancy termination must be addressed 
sensitively according to the beliefs of the target population. 
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3.4 TAY-SACHS CARRIER SCREENING 
Although the population screening programs for SCD and SCT among the adult African 
American childbearing population were unsuccessful, the Tay-Sachs carrier screening program 
among the Ashkenazi Jewish population has given evidence that a targeted genetic carrier 
screening program can be successful. We plan to utilize the experiences of this effective 
population screening program to the development of more effective screening program for SCD 
and SCT.  
Genetic carrier screening programs for Tay-Sachs disease among the Ashkenazi Jewish 
population began in the 1970’s alongside the sickle cell screening programs for African 
Americans; however, Tay-Sachs screening has experienced widespread community acceptance 
and has successfully reduced the incidence of Tay-Sachs disease by over 90% (M. Kaback et al., 
1993; M. M. Kaback, 1977). Tay-Sachs is an autosomal recessive disorder which results in 
severe neurological damage and mental retardation in those affected. Since 1970 more than 1.4 
million individuals worldwide have been voluntarily screened to determine if they are carriers 
for Tay-Sachs disease (M. M. Kaback, 2000). Lessons learned from the Tay-Sachs disease 
screening model include a need for educational and counseling components before and after 
testing within a population screening program. Additional concerns include the privacy and 
confidentiality of participants, insurability, quality control of testing, and the level of 
communication between the health community and the target population (M. M. Kaback, 2000).  
From the initial planning stages of the Tay-Sachs screening model, community leaders, 
health professionals, and religious advisors were involved in order to ensure the target 
populations participation (M. Kaback et al., 1993).  
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 Australian Tay-Sachs screening programs have utilized educational sessions as a 
method of promoting acceptance of screening among high school students resulting in a high 
retention of knowledge up to six years later and an increased positive attitude towards genetic 
testing and genetic counseling (Barlow-Stewart et al., 2003). A study performed by Becker et. al. 
utilized the Health Beliefs model to assess motivations for voluntary participation in Tay-Sachs 
carrier screening programs (Becker, Kaback, Rosenstock, & Ruth, 1975).  Participants of the 
program were found to 1) desire future children, 2) belief that they had a high risk of being a 
carrier, 3) believed that learning of carrier status did not hold extreme consequences, 4) 
understood that testing in pregnancy is available for at risk pregnancies, 5) feel favorably 
towards the termination of an affected fetus, and 6) do not believe that the psychosocial affects 
of carrier testing are severe (Becker, Kaback, Rosenstock, & Ruth, 1975).  
 
3.5 THE HEALTH BELIEF MODEL 
The Health Belief Model was first described in the U.S. Public Health Services by a group of 
psychologists in order to understand the failed acceptance of disease prevention and screening 
services among various populations (Janz & Becker, 1984). Health screening behavior was 
determined to be driven by a combination of: 1) the individual’s perceived susceptibility to the 
condition, 2) the individual’s perceived seriousness of the condition, 3) the individual’s 
perceived benefit of the specific behavior, and 4) the individual’s perceived barriers to the 
behavior (Champion, 1984).  
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Use of the Health Belief Model has been successful in assessing and motivating health 
behavior change among African Americans in regards to cancer screening, genetic information, 
and utilization of health care resources for sickle cell patients, diabetic health care compliance, 
and sexual practices over a range of age groups (K. Ashing-Giwa, 1999; C. M. Brown & Segal, 
1996; K. M. Brown, 2005, hsc.usf.edu/~kmbrown/Health_Belief_Model_Overview.htm; Byrne, 
Walsh, & Murphy, 2005; Douglass, Bartolucci, Waterbor, & Sirles, 1995; Doukas, Localio, & 
Li, 2004; Elliott, Morgan, Day, Mollerup, & Wang, 2001; Farquharson, Noble, Barker, & 
Behrens, 2004; Foxall, Barron, & Houfek, 1998; Frank, Swedmark, & Grubbs, 2004; Gipsh, 
Sullivan, & Dietz, 2004; Graham, Liggons, & Hypolite, 2002; P. M. Green & Kelly, 2004; 
James, Campbell, & Hudson, 2002; Juniper, Oman, Hamm, & Kerby, 2004; Lewis & Green, 
2000; Mashegoane, Moalusi, Peltzer, & Ngoepe, 2004; McGarvey et al., 2003; Norman & Brain, 
2005; Orr & Langefeld, 1993; K. Plowden & Miller, 2000; K. O. Plowden, 1999; Reese & 
Smith, 1997; Roden, 2004; Scollan-Koliopoulos, 2004; Sharps, El-Mohandes, Nabil El-
Khorazaty, Kiely, & Walker, 2003; Steers, Elliott, Nemiro, Ditman, & Oskamp, 1996; Wiebe & 
Christensen, 1997).  
It has been shown that health beliefs differ between African Americans and Caucasians 
(Barroso et al., 2000; Foxall, Barron, & Houfek, 1998). African American women who perceive 
fewer barriers to screening, perceive more benefits to pursuing screening, have an increased 
perception of susceptibility, and have confidence in the accuracy of screening are more likely to 
undergo screening for cancer (Frank, Swedmark, & Grubbs, 2004; P. M. Green & Kelly, 2004; 
James, Campbell, & Hudson, 2002). Increased understanding and knowledge of screening 
methods and the disease state also increase these factors (Frank, Swedmark, & Grubbs, 2004; P. 
M. Green & Kelly, 2004; James, Campbell, & Hudson, 2002). The health belief model has been 
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used in the assessment of utilization of health care facilities by sickle cell patients, suggesting 
that the health beliefs pose modifiable psychosocial variables that could be used in development 
of interventions to reduce health care costs (Reese & Smith, 1997).   
A prenatal hemoglobinopathy screening program identifying carriers introduced three 
decisions a carrier mother must make: 1) whether to accept counseling, 2) whether to have her 
partner tested, and 3) whether to accept prenatal diagnosis (Rowley, Loader, Sutera, Walden, & 
Kozyra, 1991). Multiple factors affect this decision process, with the health belief model 
identifying motivators within the carrier mothers perceived belief that their partner is a carrier, 
knowledge of the disorder, perceived barriers to testing, perceived seriousness of the disorder, 
and desire to have additional children (Rowley, Loader, Sutera, Walden, & Kozyra, 1991). Yet 
the health belief model has not been used to assess motivations among the African American 
childbearing population to pursue sickle cell trait testing in themselves.  
 30 
4.0  MATERIALS AND METHODS 
4.1 PARTICIPANTS 
A partnership between Magee Women’s Hospital and Children’s Hospital of Pittsburgh was 
formed as part of a community-based educational strategy to raise awareness of SCD and the 
importance of SCT follow up. African American women, above the age of 18 who were 
obtaining blood work by the Magee Outpatient Obstetrics and Gynecology Clinic’s lab were 
invited to participate in an anonymous survey and short educational session regarding SCD and 
SCT. Participants included women who were pregnant as well as women who were receiving 
gynecological care. Ethnicity was used as inclusion criteria due to the high incidence of SCT 
among individuals of African American descent. As stated previously, 1 in 12 African 
Americans are at risk to be carriers. Females were identified as the largest consumer of care 
within the Obstetrics and Gynecology clinic and the usual parent member in charge of family 
health care.  
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4.2 SPECIFIC AIM I: KNOWLEDGE OF SICKLE CELL DISEASE AND 
ACCEPTANCE OF GENETIC TESTING AND COUNSELING 
The initial experimental design was approved by the University of Pittsburgh Institutional 
Review Board (IRB) as a portion of a larger protocol entitled, “A Community Based Model for 
Improving the Acceptance of Newborn Screening Follow-Up, Family Testing and Genetic 
Counseling for Sickle Cell Disease and Trait.” This protocol began as a study protocol entitled 
“Western Pennsylvania Sickle Cell Network: An Integrated System of Care for the Enhancement 
of Newborn Screening Follow-Up.” This protocol was originally approved by the Children’s 
Hospital of Pittsburgh Human Rights Committee in 2002 which has been modified and renewed 
yearly by the University of Pittsburgh Institutional Review Board. (Replications of IRB 
Approval letters for protocol #0405149/ 02-138 can be found in Appendix A.) 
Initially this study aimed to improve acceptance of genetic testing and genetic counseling 
for SCT through brief educational sessions and improving knowledge of SCD and trait. An 
anonymous survey (Appendix B) assessing knowledge of SCD and SCT, acceptance of genetic 
testing, and demographic information was administered prior to the participant receiving SCD 
education. A brief five minute educational session was presented by a sickle cell community 
educator describing the inheritance and etiology of SCD and the importance of understanding 
SCT. Sessions were administered individually. Educational sessions were accompanied by visual 
aids and take home brochures. An outline of the brief educational session, including the visual 
aids and handouts given to participants can be found in Appendix C. 
After the brief educational session, an identical anonymous questionnaire was 
administered to assess a change in knowledge of SCD and any change in acceptance of genetic 
carrier screening and genetic counseling. This portion of the study and survey questions were 
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modeled after the study performed by Barlow-Steward et.al. assessing the effect of education on 
Tay-Sachs carrier screening acceptance (Barlow-Stewart et al., 2003).  
Following education and interviews with approximately 80 participants, it was believed 
that the study could be improved by assessing the psychosocial aspects that influenced 
acceptance of SCT testing among the African American population. We wanted to be able to 
better determine which factors must be emphasized within an educational program in order to 
increase motivation for pursuing genetic testing for SCT. 
4.3 SPECIFIC AIM II: KNOWLEDGE OF SICKLE CELL DISEASE AND HEALTH 
BELIEFS 
Modifications to the study protocol were submitted to and approved by the University of 
Pittsburgh Institutional Review Board under the IRB approval #0405149 to incorporate 
assessment of the sickle cell disease health beliefs into the survey of the target population in 
December of 2005 (Appendix A). Knowledge of SCD and demographic information was also 
included in this survey. Knowledge of SCD was assessed using 8 multiple choice questions 
modeled after a survey administered to school age children to assess knowledge of SCD 
(Koontz, Short, Kalinyak, & Noll, 2004). The Health Belief survey was modeled after those used 
among African American women to assess motivations for participation in cancer screening 
programs (Barroso et al., 2000; Foxall, Barron, & Houfek, 1998). A 5-point Likert scale response 
system was used to assess the health beliefs of perceived susceptibility, perceived seriousness, 
perceived benefit of action, and perceived barriers to action. A score of 1 indicated strongly 
disagree, or a low level, and 5 indicated strongly agree or a high level, as recommended by 
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Champion (Champion, 1984; Champion & Scott, 1997). The knowledge and health beliefs 
survey (Appendix D) was given to participants prior to receiving a brief educational presentation 
on the inheritance and etiology of SCD and the importance of understanding SCT. The 
assessment was performed before educating the population in order to avoid influencing the 
answers and to obtain a representative sample of the current state of knowledge and the health 
beliefs of the African American female population. Following the brief educational presentation 
participants were given an educational brochure and contact information of the Children’s 
Hospital of Pittsburgh Sickle Cell Clinics’ community educator.  An outline of the brief 
educational session as well as the visual aids and handouts given to participants can be found in 
Appendix C.  
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5.0  DATA ANALYSIS 
5.1 SPECIFIC AIM I: KNOWLEDGE OF SICKLE CELL DISEASE AND 
ACCEPTANCE OF GENETIC TESTING AND COUNSELING  
Answers to the knowledge of SCD and SCT and acceptance of genetic testing and genetic 
counseling questions were transformed into dichotomous variables. Correct answers to the 
knowledge questions were coded as 1, incorrect or unsure answers were coded as 0. A maximum 
score of 6 was possible for knowledge of SCD. Positive answers with each attitude question 
towards genetic testing and counseling questions were also coded as 1, negative or unsure 
answers were coded as zero, with a maximum positive score of 5. Utilizing Stata 7.0 statistical 
software package the knowledge and acceptance scores prior to and following the educational 
program were compared using the Wilcoxen paired t-test. Acceptance of SCT testing and genetic 
counseling and knowledge of SCD were analyzed for correlation to determine if they were 
significantly related. Linear regression was used to determine which demographic variables 
significantly predicted the level of acceptance of genetic testing prior to receiving SCD 
education. Population means were also determined to level of knowledge and acceptance prior to 
and following receiving SCD education.  
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5.2 SPECIFIC AIM II: KNOWLEDGE OF SICKLE CELL DISEASE AND HEALTH 
BELIEFS 
Correct answers to the sickle cell knowledge questions were given a score of 1, with a total 
maximum score of eight possible. A five point Likert-scale was used for assessment of perceived 
severity, susceptibility, benefits and barriers with 5 indicating a high perception, and 1 indicating 
a low perception. Stata 7.0 statistical software was used to determine the populations mean 
perceived severity of SCD, susceptibility to SCD, benefits to SCT testing, and perceived barriers 
to trait testing. Each health belief was analyzed along with knowledge scores of sickle cell 
disease to determine correlation. Linear regression was used to determine which demographic 
characteristics significantly predicted the perceived health beliefs.   
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6.0  RESULTS 
6.1 SPECIFIC AIM I: KNOWLEDGE OF SICKLE CELL DISEASE AND 
ACCEPTANCE OF GENETIC TESTING AND COUNSELING  
The population surveyed for knowledge of SCD and acceptance of genetic counseling and 
testing were primarily within the ages of 20-25 (34.5%), were high school graduates (32.6%), 
single (87.5%) with no children (35.9%), and were insured (86.7%) (See Figures 6-10).  
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Figure 6: Highest Education Completed of Knowledge and Acceptance Survey Participants  
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Figure 7: Age Distribution of Knowledge and Acceptance Survey Participants 
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Figure 8:  Marital Status of Knowledge and Acceptance Survey Participants 
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Figure 9: Number of Children of Knowledge and Acceptance Survey Participants 
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Figure 10: Insurance Status of Knowledge and Acceptance Survey Participants 
 
 
 
The mean knowledge score prior to receiving the brief educational programming was 
2.62 (± 1.39) (43.66% correct) on a maximum of 6 possible correct answers. Following the 
education the mean knowledge was 4.65 (± 1.04) (77.5% correct). The level of knowledge 
following education was significantly greater than knowledge of SCD prior to education, with a 
p-value < 0.001 (Figure 11).  
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prior to educational 
session 
2.62 ± 1.39 
(43.66% correct) 
Average knowledge score 
following educational 
session 
4.65 ±1.04 
(77.5% correct) 
  Significant difference seen with a p-value < 0.001 
 
 
Figure 11: Knowledge of SCD Prior to and Following Brief Educational Session 
 
 
Acceptance of SCT testing and genetic counseling was scored at a mean of 3.72 (± 1.39) 
prior to education, and at 4.30 (± 0.87) following education. The acceptance scores were 
significantly greater following education with a p-value < 0.001 (Figure 12). 
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Figure 12: Acceptance of Genetic Testing and Genetic Counseling of SCD and SCT Prior to and 
Following SCD Education 
 
 
When analyzed for correlation, an increase in knowledge of SCD was found to be only 
25.6% correlated with an increase in acceptance of SCT testing and genetic counseling. 
Demographic data were analyzed for predictors of acceptance level prior to receiving the 
educational program. The only significant predictors for a high level of acceptance were 
insurance status and knowledge of SCD (p-value < 0.05) (Table 4).  
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 Table 4: Linear Regression Analysis of Variables as Predictors of Acceptance Level  
 
VARIABLE ASSESSED P-VALUE 
(* INDICATES SIGNIFICANCE) 
Knowledge of SCD 0.000 * 
Education 0.078 
Age 0.071 
Marital Status 0.235 
Number of Children 0.899 
Insurance Status 0.023 * 
 
 
6.2 SPECIFIC AIM II: KNOWLEDGE OF SICKLE CELL DISEASE AND HEALTH 
BELIEFS 
Forty Five women have been surveyed at this time regarding their perceived health beliefs 
regarding SCD and SCT testing.  The population surveyed for knowledge of SCD and perceived 
health beliefs averaged in age 20-24 (30%), were high school graduates (40%), and were single 
(84%), with an average of one child (32%). Forty three percent of participants currently live with 
their partner (Figures 13-17).  
 
 45 
18-19
18%
20-24
30%
30-34
16%
35-39
5%
40-44
2%
45+
2%
25-29
27%
18-19 20-24 25-29 30-34 35-39 40-44 45+
 
 
Figure 13: Age Distribution of Health Beliefs Survey Participants 
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Figure 14: Highest Completed Education of Health Beliefs Survey Participants 
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Figure 15: Marital Status of Health Beliefs Survey Participants 
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Figure 16: Living Arrangements of Health Beliefs Survey Participants 
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Figure 17: Number of Children of Health Beliefs Survey Participants 
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The cumulative mean perceived severity prior to education was high at 4.45 (± 0.921) on 
the 5-point Likert scale. The cumulative perceived susceptibility was moderate at 2.64 (± 0.963) 
on the 5-point Likert scale. The cumulative perceived benefit to testing was high at 4.03 (± 
1.026), and cumulative perceived barriers to testing was low to moderate at 2.31 (± 0.900). The 
mean knowledge score was moderate at 4.44 (± 1.73) on scale with a maximum score of 8 points 
(Figure 18, Table 5).  
 
 
 
  
1
5
Strongly Disagree-Low 
Strongly Agree-High 
 
Health 
Beliefs 
 
5-Point 
Likert 
Scale 
Perceived 
Severity of SCD 
4.45 ± 0.921 
Perceived 
Susceptibility 
to SCD 2.64 ± 
0.963 
Perceived 
Benefit to SCT 
testing 
4.03 ± 1.026 
Perceived 
Barriers to 
SCT Testing 
2.31 ± 0.900 
 
Figure 18: Average Cumulative Health Beliefs of African American Female Participants 
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 Table 5: Summary of Knowledge of SCD and Health Beliefs Survey Results 
 
SUMMARY OF KNOWLEDGE OF SCD AND HEALTH BELIRFS SURVEY RESULTS 
(* CUMULATIVE INDICATES ALL APPLICABLE ANSWERS HAVE BEEN AVERAGED TO 
STANDARD LEVEL OF SPECIFIC HEALTH BELIEF) 
Question Population 
Mean 
 
Standard 
Deviation 
Minimum     Maximum 
Knowledge of SCD 4.44  correct 1.73 0  correct 8 correct 
Severity (Cumulative) * 4.45 0.92 1 5 
Sickle Cell Disease is a 
serious disease 
4.46 0.96 1 5 
Having a Child with SCD 
would be very scary 
4.44 1.03 1 5 
My life would change if 
my child had SCD 
3.82 1.21 1 5 
Susceptibility 
(Cumulative) * 
2.64 0.96 1 5 
My children are at risk for 
SCD 
2.06 1.18 1 5 
SCD could happen in my 
family 
3.39 1.34 1 5 
My partner may be a 
carrier of sickle cell trait 
2.40 1.45 1 5 
Benefit (Cumulative) * 4.03 1.02 1 5 
It is useful to know if I 
have sickle cell trait 
4.28 1.19 1 5 
It is useful to know if my 
partner has sickle cell trait 
4.39 1.19 1 5 
Knowing the risk of 
having a child with SCD 
would change how I plan 
my pregnancy 
3.48 1.32 1 5 
Barriers(Cumulative) * 2.31 0.90 1 5 
Testing for sickle cell trait 
is painful and difficult 
1.97 1.13 1 5 
My partner would be hard 
to convince to have testing 
2.15 1.38 1 5 
I do not want to pay for 
sickle cell trait testing if it 
is not paid for by 
insurance 
2.80 1.47 1 5 
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 The Spearman rank correlation function was used to determine correlation between 
knowledge of SCD score and the health beliefs. A Spearman’s rho value of 1 indicates a perfect 
positive correlation, a rho of -1 indicates a perfect negative correlation, and a rho of zero 
indicates that the values are completely independent of each other. A weak positive correlation 
was found between the level of knowledge and the perceived severity of SCD and between the 
level of knowledge and the perceived benefit to testing with a p-value < 0.05. A statistically 
significant correlation was not found between the knowledge of SCD and the perceived 
susceptibility and perceived barriers to testing (Table 6).  
 
 
Table 6: Spearman Rank Correlation between Knowledge of SCD and Health Beliefs 
 
SPEARMAN RANK CORRELATION BETWEEN KNOWLEDGE OF SCD AND 
HEALTH BELIEFS 
 
(SPEARMAN’S RHO INDICATES THE DEGREE OF RELATION, WITH A RHO OF 1 INDICATING A 
STRONG POSITIVE CORRELATION, -1 INDICATING A STRONG NEGATIVE CORRELATION, AND A RHO 
OF 0 INDICATING COMPLETE INDEPENDENCE OF THE VARIABLES) 
Health Belief Spearman’s Rho p-value 
* indicates 
significance 
(p< 0.05) 
Severity 0.3455 0.0201 * 
Susceptibility 0.0210 0.8935 
Benefit 0.4459 0.0027 * 
Barriers 0.1861 0.2209 
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Linear regression was used to determine the relationship between the demographic data 
and the health beliefs. Perceived severity was significantly predicted by knowledge of SCD only, 
with a p-value < 0.05. Perceived susceptibility to SCD, perceived benefit to testing, and 
perceived barriers to testing was not significantly predicted by any of the demographic variables 
available (Table 7).  
 
 
Table 7: Linear Regression Analysis of Variables and Health Beliefs 
 
LINEAR REGRESSION ANALYSIS OF VARIABLES AND HEALTH BELIEFS 
  p-value 
* indicates significance 
(p<0.05) 
Perceived Severity of SCD Knowledge of SCD 
Education 
Age 
Living Arrangement 
Marital Status 
Number of Children 
0.005 * 
0.486 
0.305 
0.492 
0.808 
0.427 
Perceived Susceptibility of SCD Knowledge of SCD 
Education 
Age 
Living Arrangement 
Marital Status 
Number of Children 
0.821 
0.670 
0.112 
0.297 
0.304 
0.367 
Perceived Benefit of sickle cell trait 
testing 
Knowledge of SCD 
Education 
Age 
Living Arrangement 
Marital Status 
Number of Children 
0.095 
0.864 
0.303 
0.811 
0.612 
0.483 
Perceived Barriers to sickle cell 
trait testing 
Knowledge of SCD 
Education 
Age 
Living Arrangement 
Marital Status 
Number of Children 
0.108 
0.232 
0.147 
0.640 
0.978 
0.262 
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7.0  DISCUSSION 
7.1 SPECIFIC AIM I: KNOWLEDGE OF SICKLE CELL DISEASE AND 
ACCEPTANCE OF GENETIC TESTING AND GENETIC COUNSELING 
Overall this study has shown that a brief educational session is effective in both increasing 
knowledge of SCD and increasing the level of acceptance of genetic testing and screening for 
SCT among the African American female community of childbearing age.   
A brief individual educational session utilizing visual aids and take home materials given 
in the prenatal setting was found to significantly increase the level of knowledge of SCD with a 
p-value < 0.001 among the participants. This is important in establishing evidence that providing 
education and informational materials regarding SCD and SCT during pregnancy is a good time 
to access the childbearing population of African American women at risk to have SCT.  
Although the prenatal visit is very busy with a large amount of information shared, the addition 
of information regarding SCD and SCT did not show to be an undue burden to the participants.  
The brief educational session regarding the etiology and inheritance of SCD and SCT 
was also shown to significantly increase the level of acceptance of genetic testing and genetic 
counseling for SCT (p-value < 0.001).  Prior to receiving the educational material the acceptance 
levels of the surveyed population had a large spread, with the average score moderately high on a 
5-point scale. Following the educational session the spread minimized, and elevated to a higher 
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acceptance score, indicating that minimal education on the etiology and inheritance of SCD and 
SCT can positively affect the acceptance of genetic testing and genetic counseling for SCT.   
A correlation study was performed and revealed that an increase in acceptance was 
correlated with an increase in knowledge of SCD only 25.6% of the time. This was lower than 
hypothesized but may be limited by the size of the study and the small scale of the assessment 
tool. With such a small assessment tool, an individual with an initial moderate to high acceptance 
level can show only limited increase, regardless of the level of increase in their SCD knowledge. 
For future studies a longer, more in depth assessment tool may be warranted in order to further 
define the levels of SCD knowledge and the level of acceptance. Unfortunately, a longer more in 
depth assessment tool may reduce interest in participation. Overall the majority of women 
invited to participate were receptive when assured that participation did not demand a large time 
commitment. Common reasons for declining participation were a lack of time and outside 
distractions such as small children. One proposed method for further study may be to access 
participants at a different point in care, as part of their visit intake paperwork, or to access 
women of childbearing age at a different venue such as outside the clinic at hair and nail salons.  
Linear regression analyses of the demographic variables assessed in this survey were 
studied for predictors of a high initial level of acceptance, prior to receiving any SCD and SCT 
education. It was found that the initial knowledge of SCD as well as having health insurance 
were the only two significant predictors of a high level of acceptance (p-value < 0.05). This 
further emphasizes that knowledge of SCD does in fact influence the acceptance of SCT testing, 
indicating that education of SCD is an effective manner to increase interest in testing.  
It is logical that insurance status is also a predictor of the acceptance level for testing. The 
African American community is commonly associated with lower socioeconomic standards, and 
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without insurance coverage, additional testing and screening that is not considered emergent may 
cause additional economic burden, causing a decrease in the acceptance and interest in genetic 
screening for an uninsured individual.  Further research and outreach for SCD and SCT should 
take this concern into account and consider the benefits of offering testing for SCT at no cost or 
at a reduced cost, as a way to increase the interest and acceptance in SCT testing.  
This project did show that education can increase the acceptance of SCT testing and 
genetic counseling for SCD and SCT; however, after educating and surveying approximately 80 
participants it was decided that it may be of further benefit to understand the predictors of a high 
acceptance and the motivations, or lack of motivations, that are limiting the interest in SCT 
testing among the African American childbearing community. From this question the Health 
Belief Model was developed to study the African American childbearing populations’ beliefs 
regarding SCD and SCT testing. 
This study is limited in that the participants were only women who were actively 
pursuing health care. It is possible that this may be a cause of bias in the data. This is because 
these women represent a population that may already have a higher understanding and 
acceptance of health care and testing. Unfortunately, the ability to assess the knowledge and 
acceptance levels of all African American women of childbearing age in the area is limited by 
our own ability to access the population. However, one can also argue that as one of the largest 
prenatal health care facilities for the Pittsburgh area, Magee Women’s Hospital facilitates cares 
for all levels of socioeconomic status, and may be one of the most representative samples of the 
area’s female population of childbearing age. Future research should be conducted among 
traditionally underserved populations and become creative in areas of outreach and education. 
Community groups such as women’s guilds, churches, youth groups, salons and barbershops 
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may provide other avenues for reaching a population that may not actively pursue health care 
and testing. 
Another limitation of this study is that we did not assess whether the participants had had 
prior education on SCD and SCT, or whether the participants had ever been tested for SCT. 
These are both possible sources of bias in our data. It is possible that those who have had testing 
and genetic counseling prior to participating would have an increased level of acceptance of 
testing and counseling.  
Although this study does show that women receiving education on SCD during a busy 
prenatal visit can in fact learn the information, it does not indicate how well this information will 
be retained in the long run. It would be useful to address the retention of the information given 
on SCD and SCT following the conclusion of the pregnancy, being this is the time where they 
will be experiencing newborn screening for hemoglobinopathies. With the Children’s Hospital of 
Pittsburgh Comprehensive Sickle Cell Program contracted to follow-up with all of the families 
of infants identified to have an abnormal hemoglobinopathy or hemoglobinopathy trait in the 
Western Pennsylvania area, access is possible to reach a group where an increase in knowledge 
and understanding of SCD and SCT may be seen among mothers who received prenatal 
education. Unfortunately this newborn screening follow up program will only reach the small 
population of mothers where an infant has been identified to have an abnormal screen, losing to 
follow up the majority of women who received the SCD and SCT education that will not have an 
infant identified to have an abnormal hemoglobinopathy trait.  It is of benefit to assess the 
knowledge of SCD and SCT among mothers of infants identified to have an abnormal 
hemoglobinopathy newborn screen prior to their receiving genetic counseling, as this will 
provide a representation of how aware those truly at risk for an infant to have SCT or SCD are. 
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7.2 SPECIFIC AIM II: KNOWLEDGE OF SICKLE CELL DISEASE AND HEALTH 
BELIEFS 
The Health Belief Model theorizes that pursuit of a health screening program will occur when an 
individual believes that the heath concern is serious enough to warrant screening, that they are at 
risk for the disorder, they believe that there is a benefit to pursuing the screening and that the 
barriers to pursuing screening are low (K. M. Brown, 2005, 
hsc.usf.edu/~kmbrown/Health_Belief_Model_Overview.htm; Janz & Becker, 1984). Utilizing 
the Health Belief Model among a population of 45 African American women of childbearing age 
determined that the majority of this population believes that SCD is a severe disease, with a 
perceived severity of 4.45 ± 0.921 on a 5-point Likert scale. Initially it was hypothesized that the 
reason individuals are not pursuing SCT screening is because they do not believe it to be severe 
enough to warrant testing. The Health Belief Model indicates that this is not the case.  
The women surveyed indicated that they do not believe that they are at an increased risk 
for SCD, with a perceived susceptibility to SCD of 2.64 ±0.963. Many participants reported that 
“Sickle cell disease just doesn’t run in my family,” indicating they believe they were not at risk. 
Unfortunately, as with many recessive disorders, the family is often unaware of the gene in their 
family until someone is born with the disease, and so screening of sickle cell trait is still 
warranted. According to the Health Belief Model, in order to pursue a health screening behavior 
an individual must think that they are susceptible. This study indicates that the most likely 
limiting motivator to pursuing SCT screening is that the population does not perceive themselves 
at sufficient risk. Sickle cell trait carriers are healthy and will not experience any symptoms of 
SCD. It is understandable that it may be difficult for individuals to believe that they may be at 
risk to have a child with a severe illness because they themselves are healthy, and no one in their 
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family has had the same experience. Future studies should address why members of the African 
American population of childbearing age do not believe that they are at risk for having children 
with SCD. This information would be useful to effectively target health education interventions 
towards motivating individuals to pursue genetic testing and genetic counseling for SCT. Focus 
groups provide a method for utilizing the information obtained in this study to further address the 
lack of perceived susceptibility among the African American population of childbearing age. 
Focus groups provide the opportunity for members of the target population to voice their 
opinions and thoughts on how the health community could sensitively address the beliefs of the 
community in a culturally appropriate and effective manner. Interviews of members of the 
African American community of childbearing age who are and who are not actively pursuing 
health care should probe into the reasons and underlying beliefs that are causing this population 
to believe that they are not at risk to have SCD in their family. Information obtained from these 
targeted interviews could then be used to develop the educational materials that will be the most 
effective in motivating this population to pursue SCT testing and genetic counseling.  
A limitation of this study is that it was not assessed whether participants in this study 
already knew their trait status prior to filling out their health beliefs. If they previously were 
aware of their own SCT status as well as that of their partner, they would be correct in indicating 
that their children were not at risk for SCD. This is a limitation and flaw to this survey that future 
studies should also address. Variance in health beliefs may be seen between individuals who 
know their trait status and those who do not.   
Prior to being educated on the etiology of SCD and the importance of being aware of 
SCT, the population of African American women surveyed believed that there is a high benefit 
to testing for SCT, with a perceived benefit to testing of 4.03 ± 1.026 on a 5-point scale. The 
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Health Beliefs Model reports that in order for an individual to pursue testing, they must believe 
that the screening behavior has a high benefit. This study indicates that the African American 
community already believes that screening for SCT is beneficial, prior to being educated on the 
importance of genetic screening for SCT. This indicates that this area may not need to be 
emphasized as much in future education, because according to the Health Belief Model, this is 
not the rate limiting motivator for pursuing SCT screening. Education of the benefits of testing 
should not be neglected however, because there will always be someone who is at risk who is 
unaware of the benefits of testing.   
The perceived barriers to testing were low with an average of 2.31 ± 0.900, indicating 
that this is unlikely to be what is causing the lack of interest in genetic testing for SCT, according 
to the Health Belief Model. Interestingly, one of the questions of barriers inquired on the 
willingness to pay for SCT screening if it is not covered by insurance. This question returned 
with the highest barrier score, indicating that insurance coverage of testing may affect the 
willingness of the at risk population to pursue testing. As discussed previously, the African 
American population is often largely of a lower socioeconomic status; they may find that paying 
for additional testing that is not emergent is an unnecessary financial burden. Future studies 
should take this concern into account and consider different ways to supply testing at little to no 
cost to the patient who needs financial help.  
Spearman rank correlation was utilized to determine if the knowledge level of SCD was 
related to the health beliefs of this population. The average SCD knowledge score among the 
population surveyed was moderate, at 4.44 ± 1.73, on a maximum scale of 8 correct answers. 
Evaluation with Spearman’s rank correlation found a significant relationship between the level of 
SCD knowledge and the perceived severity of SCD (p-value < 0.05).  Individuals with an 
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increased level of knowledge of SCD seem to also have an increased belief that the disorder is 
severe. This supports the earlier hypothesis that increasing education and knowledge of SCD will 
increase the motivations towards pursuing SCT testing by exhibiting that improving knowledge 
increases the belief that the disorder is severe enough to warrant screening. A positive correlation 
was also exhibited between the level of knowledge of SCD testing and the perceived benefit to 
testing with a p-value < 0.05. This also supports the hypothesis that increasing knowledge and 
understanding of SCD will motivate African American women of childbearing age to pursue 
SCT testing by increasing their perception of the benefit to testing.  
No significant correlation was found between the knowledge of SCD and the perception 
of susceptibility and barriers to testing. As discussed earlier the perception of susceptibility could 
be influenced by knowledge of SCD; however, it also likely to be strongly influenced by 
established family myths, and the belief that if they are healthy and their family is healthy they 
are unlikely to have children at risk for SCD. Family beliefs are often very strong and difficult to 
influence, even by facts and knowledge because these are the beliefs that individuals learn 
throughout their whole life and have experienced first hand. Sensitivity and respect of these 
family beliefs and myths is important to establish in order to connect with patients and 
successfully educate these families. Future studies must take into account that emotional, 
strongly embedded family histories and beliefs may be influencing how the at-risk population 
perceives health information and genetic screening information. Educational material should also 
acknowledge these myths and stories because these lingering beliefs may clash with the 
scientific fact. In order to accurately educate at-risk individuals, these stories should be 
addressed sensitively in education, and not ignored.  
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Barriers to testing for SCT were not found to be significantly correlated with the level of 
knowledge of SCD. Although the perceived barriers were low, it is possible that the perceived 
barriers to testing may be beyond the scope surveyed for in this study. This study addressed the 
cost of testing and insurance coverage, the participation of partners, and the difficulty of testing; 
however, other barriers such as limited access to testing, socioeconomic status, not knowing 
where testing is available and inability to travel to a testing site may also exist as barriers to 
pursuing testing that have not been addressed. Future studies should address all levels of possible 
barriers to pursuing testing that were not addressed here.  
Demographic variables assessed in this study include the age of the participants, the 
marital status, whether they lived with their partner, their highest education level achieved, and 
the number of children they currently had. It was hypothesized that younger participants with 
fewer children may be more interested in knowing their risks for future children than those 
participants who had already had many children. Marital status and living situation was also 
thought to increase an individual’s interest in pursuing testing because they would be more likely 
to have an active partner in their pregnancy. Education was thought to be likely correlated to a 
higher understanding of SCD and SCT testing as well as a higher socioeconomic status. 
However linear regression analysis did not find any significant relationship between any of the 
health beliefs and any of these demographic measures. This study is limited in that it did not 
directly address socioeconomic status as a possible influential demographic factor. 
Transportation issues have also been hypothesized as a limitation for individuals to pursue health 
care and testing for SCT, making this another candidate for future assessment.  
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7.3 CONCLUSIONS 
This study was successful in exhibiting that education of SCD in a prenatal setting can influence 
the knowledge of SCD and the acceptance of genetic testing for SCT. The feasibility for 
establishing a successful model of education of SCD within a prenatal setting is high as long as 
the participation is found between all parties involved.  It was found that only minimal education 
was necessary to improve the knowledge SCD and the acceptance of SCT testing. The majority 
of the individualized educational sessions were performed in less than 5 minutes.  
Characterization of the current state of health beliefs of the African American 
childbearing population is still in process, as the sample size is a large source of limitation in 
making final conclusions on the data. According to the data at this point, the health belief that 
seems to be influencing the lack of interest in pursuing screening for SCT among the population 
surveyed is the low belief that they are individually at risk for being carriers of SCT.  Outreach 
methods that target these beliefs should be sensitive and respect cultural beliefs. Future proposed 
use of this data plans to incorporate the results into focus group interviews and education 
planning sessions with members and leaders of the African American community, in order to 
improve the public educational materials on SCD and SCT screening. Utilizing input of the 
target population is an important step in establishing a genetic screening program.  
Much was learned throughout the process of developing and implementing this study. 
First of all, it became clear early on that success of this project would only occur with an open 
and active partnership of all parties involved. Without the support of Magee Women’s Hospital 
participation would have been very limited. However, as discussed earlier, this may have added 
some additional limitations and bias into our study by only supplying participants who are 
already in a heightened state of awareness of the importance of health care and testing. These 
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participants have actively pursued prenatal care and so may already be more open to health care 
information and additional testing than the general population of African American women of 
childbearing age. It was thought though that limiting participants to those individuals who are 
currently pregnant are also those most likely to benefit from the information prior to dealing with 
the results of newborn screening. When these participants deliver, a small percentage of them 
will be identified by the Western Pennsylvania Sickle Cell Comprehensive Sickle Cell Program, 
and this early experience with information on SCD and SCT may reduce the shock of this 
contact regarding their newborns hemoglobin status.  
As the Western Pennsylvania Sickle Cell Comprehensive Sickle Cell Program continues 
to educate and access members of the African American community through outreach and 
newborn screening follow up it is crucial that they consider the implications of the information 
disseminated. Further development of these materials must take into account the unique beliefs 
of the community at risk in order to develop a successful partnership. Simple education can be a 
success, however for maximum success educational materials need to sensitively address the 
beliefs of the population that are leading to a lack of motivation for testing, particularly the belief 
that they are not at risk for SCD and SCT.  
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APPENDIX A 
INSTITUTIONAL REVIEW BOARD APPROVAL LETTERS 
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APPENDIX B 
KNOWLEDGE OF SICKLE CELL DISEASE AND ACCEPTANCE OF GENETIC 
TESTING FOR SICKLE CELL TRAIT SURVEY 
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 SICKLE CELL DISEASE AWARENESS AND BELIEFS REGARDING 
CARRIER TESTING 
 
PRE-EDUCATION QUESTIONAIRE: PLEASE CHECK WHETHER YOU AGREE, DISAGREE, OR ARE 
UNCERTAIN ABOUT THE FOLLOWING STATEMENTS 
 AGREE DISAGREE UNCERTAIN
Sickle cell disease affects the red 
blood cells 
   
Children with sickle cell disease are at 
risk for infections,  
Pain, pneumonia and stroke 
   
African American are at a higher risk 
of being genetic carriers of sickle cell 
disease 
   
Genetic carriers will not develop 
symptoms of sickle cell disease 
   
Both parents must be carriers of sickle 
cell trait in order to have a baby with 
sickle cell disease 
   
If only one parent is a carrier of a 
sickle cell trait, there is no chance of 
having a baby with sickle cell disease 
   
I support sickle cell disease carrier 
testing 
   
I support sickle cell disease carrier 
testing for communities 
   
If both parents are trait carriers , 
testing in pregnancy should be offered 
   
I would encourage my partner to be 
tested for the sickle cell trait if I was 
found to be a trait carrier 
   
Having a sickle cell trait would make 
me less confident about forming 
relationships 
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POST TEST ANALYSIS: PLEASE CHECK WHETHER YOU AGREE, DISAGREE, OR ARE UNCERTAIN 
ABOUT THE FOLLOWING STATEMENTS 
 AGREE DISAGREE UNCERTAIN
Sickle cell disease affects the red blood cells    
Children with sickle cell disease are at risk for 
infections, pain, pneumonia and stroke 
   
African Americans are at a higher risk for being 
genetic carriers of sickle cell disease 
   
Genetic carriers will not develop symptoms of sickle 
cell disease 
   
Both parents must be carriers of a sickle cell trait in 
order to have a baby with sickle cell disease 
   
If only one parent is a carrier of sickle cell trait, there 
is no chance of having a baby with sickle cell disease 
   
I support sickle cell disease carrier testing    
I support sickle cell disease carrier testing for 
communities 
   
If both parents are trait carriers, testing in pregnancy 
should be offered 
   
I would encourage my partner to be tested for the 
sickle c ell trait if I was found to be a trait carrier 
   
Having a sickle cell trait would make me less 
confident about forming relationships 
   
I found information on sickle cell disease and sickle 
cell trait useful 
   
DEMOGRAPHIC DATA: PLEASE CIRCLE THE ANSWER WHICH BEST APPLIES TO YOU 
SEX: FEMALE MALE 
AGE (YEARS):  16-20 21-25 26-30 31-35 36-40 41-45 46-50 50+ 
HIGHEST EDUCATION: LESS THAN HIGH SCHOOL HIGH SCHOOL GRADUATE 
 SOME COLLEGE COLLEGE GRADUATE  GRADUATE/PROFESSIONAL SCHOOL 
MARITAL STATUS: MARRIED SINGLE DIVORCED 
NUMBER OF CHILDREN: 0 1 2 3 4+ 
INSURANCE STATUS:   INSURED NOT INSURED 
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APPENDIX C 
BRIEF SICKLE CELL DISEASE EDUCATIONAL SESSION OUTLINE 
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SICKLE CELL DISEASE AND SICKLE CELL TRAIT EDUCATIONAL 
SESSION OUTLINE 
 
1. Introduction: 
A. Working with Children’s Hospital of Pittsburgh and Magee Women’s Hospital on 
developing education on sickle cell disease and sickle cell trait 
B. Ask if patient would mind talking with me for a few minutes 
C. Explain we are talking with women about sickle cell disease and sickle cell trait 
and hoping to develop more education by finding out what the community already 
knows and believes about this disease 
D. Ask if they are over age 18 
I. Yes- ask to take the time to fill out anonymous questionnaire before giving 
education. Reassure it is not a test and that we will go over all of the 
information together 
II. No- Provide education and handouts.  
 
2. Sickle Cell Disease Education 
A. USE VISUAL AID (FIGURE 19) 
 
Figure 19: Educational Visual Aid; Sickle Cell Disease 
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 I. Sickle cell disease is a disease that affects the red blood cells 
II. Usually our red blood cells are round and soft and squishy and can carry 
oxygen from our lungs to the parts of our body that need it by squeezing 
through the small blood vessels in our body.  
III. When someone has sickle cell disease their red blood cells can become 
hard and sickle cell shaped, like a “half-moon” or “banana” shape.  
IV. This can cause these red blood cells to get stuck in the blood vessels 
causing infection, stroke, and severe pain that can result in long hospital 
visits. Sometimes this can also result in a shorted lifespan.  
V. Individuals with sickle cell disease are born with it. It is not contagious 
and you cannot get sickle cell disease from some one who has it. It is in 
our genes.  
VI. Our genes are the instructions for how our bodies work. We get half of our 
genes from our mothers and half from our fathers, making for two copies 
of every gene in our body.  
VII. The only way for someone to have sickle cell disease is to have inherited 
one gene for their red blood cells that is not working from their mother, 
and one non-working gene from their father. People with sickle cell 
disease have inherited two genes that are not working properly, causing 
their red blood cells to change shape.  
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 B. USE VISUAL AID (FIGURE 20) 
 
 
Figure 20: Educational Visual Aid; Inheritance of Sickle Cell Disease 
 
I. People who have one gene for their red blood cell that is not working 
properly and one that is are called “sickle cell trait carriers”.  
II. Sickle cell trait carriers are perfectly healthy; they do not have sickle cell 
disease and will not ever get sickle cell disease. In fact, without testing 
they may never even know that they are trait carriers. 
III. The reason it is important to be aware of sickle cell trait is because it 
becomes a concern when it is time to have children. If two people who 
carry sickle cell trait have children together, their children are at risk to 
have sickle cell disease.  
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IV. Couples who are at risk to be carriers should be tested. The only way to 
know someone is a trait carrier is to have a simple blood test. This 
information can be used to plan for the possibility of having a sick child 
and to find out more about testing and other options available in 
pregnancy.  
V.  African Americans are at the highest risk to be carriers of sickle cell trait. 
Because of this, Magee Women’s Hospital is now testing all African 
American women for sickle cell trait at the beginning of their pregnancy.  
VI. This is a genetic test that can provide information for other family 
members and so we are working on providing educational materials for 
patients concerning this test.  
 
C. QUESTIONS? 
D. SEND HOME WITH HANDOUTS REGARDING SICKLE CELL DISEASE 
AND SICKLE CELL TRAIT TESTING (FIGURES 21-24) 
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Figure 21: Educational Handout; Hemoglobin Electrophoresis (page 1) 
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Figure 22: Educational Handout; Hemoglobin Electrophoresis (page 2) 
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Figure 23: Educational Handout; Sickle Cell Trait (page 1) 
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Figure 24: Educational Handout; Sickle Cell Trait (page 2) 
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APPENDIX D 
KNOWLEDGE OF SICKLE CELL DISEASE AND HEALTH BELIEFS REGARDING 
SICKLE CELL DISEASE AND SICKLE CELL TRAIT SURVEY 
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Questionnaire for assessment of knowledge and health beliefs of sickle cell disease:  
 
Knowledge Questions: Following are some questions about sickle cell disease.  Please read each 
question very carefully and then circle one answer that is the best.  Remember, only one answer for 
each question. 
 
1) Sickle Cell Disease is caused by 
a. dirty needles 
b. a virus 
c. inheriting genes from parents 
d. bad blood  
e. none of the above 
 
 
2) How many genes must someone inherit 
to have Sickle Cell Disease? 
a. zero, it is not caused by genes 
b. one from their mom 
c. two, one from their mom, and 
one from their dad 
d. three, one from mom, and two 
from dad 
e. none of the above 
 
 
3) Sickle Cell Disease can cause 
a. severe debilitating pain 
b. strokes 
c. infections 
d. organ damage 
e. all of the above 
 
 
4) Sickle Cell Disease occurs most often  
in 
a. boys  
b. girls 
c. white people 
d. black people 
e. all of the above 
 
5) Sickle Cell Pain can feel worse 
than 
a. a broken bone 
b. a headache 
c. a gunshot wound 
d. all of the above 
e. none of the above 
 
6) Sickle Cell Disease makes red 
blood cells 
a. round and soft 
b. hard and sickle shaped 
c. sticky and blue 
d. stiff and round 
e. soft and sickle shaped 
 
 
 
 
7) Sickle Cell Disease is easily 
cured by 
a. antibiotics 
b. liver transplant 
c. rest 
d. blood transfusions 
e. none of the above 
 
8) How can you tell if someone 
carries the gene for sickle cell 
disease? 
a. They look sick 
b. They will eventually have 
Sickle Cell Disease 
c. With a simple blood test 
d. There is no way of 
knowing 
e. None of the above 
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 Health Belief Questions: 
Please rate your level of agreement with each of the following statements on a 5-point scale 
where 1 means “strongly disagree” and 5 means “strongly agree.” 
Severity 
1. Sickle Cell Disease is a serious disease 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
2. Having a child with sickle cell disease would be very scary 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
3. My life would change if my child had sickle cell disease 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
Susceptibility 
4. My children are at risk for sickle cell disease 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
5. Sickle Cell Disease could happen in my family 
Strongly Disagree  1 2 3 4 5 Strongly Agree  
6. My partner may be a carrier of sickle cell trait 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
Benefit 
7. It is useful to know if I have sickle cell trait 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
8. It is useful to know if my partner has sickle cell trait 
Strongly Disagree  1 2 3 4 5 Strongly Agree  
9. Knowing the risk of having a child with sickle cell disease would change how I plan a pregnancy 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
Barriers 
10. Testing for sickle cell trait is painful and difficult 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
11. My partner would be hard to convince to have testing 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
12. I would not want to pay for sickle cell trait testing if it is not paid for by insurance 
Strongly Disagree  1 2 3 4 5 Strongly Agree 
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Demographic Questionnaire: 
The following questions tell us more about you. Please circle or fill in the answer that best 
describes you.  
 
1. I am _____ years old 
 
 18-19 20-24       25-29       30-34    35-39      40-44       45+       
   
2. I am _____ 
 
 Single Married Divorced 
 
3. I have ____ Children 
 
 0  1  2  3  4  5+ 
 
4. I _______ live with my partner 
 
 Do   Do Not  No Partner 
 
5. The highest level of school I have finished is ___________ 
 
 Some High School  High School Graduate Some College   
  
 College Graduate  Graduate/Professional School 
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